Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Theravance Reports Positive Phase II Results For Chronic Constipation Therapy TD-5108

Jun 26 2007

• By Shirley Haley

Related Content

Zelnorm Will Be Available Under Treatment IND Following Marketing Suspension

Mar 30 2007

Theravance’s First NDA Is Antibiotic Telavancin

Dec 08 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window